US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

Analysis

Law360 Cheat Sheet: Novartis' Fight Over Generic Entresto

By Dani Kass · March 12, 2025, 9:13 PM EDT

Novartis has led a wide-ranging litigation campaign to block generic versions of its bestselling cardiovascular drug Entresto that has involved multidistrict litigation, trips to several circuit courts and cases against the...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals Inc. et al

Case Number

1:19-cv-00201

Court

West Virginia Northern

Nature of Suit

835 Patent - Abbreviated New Drug Applications (ANDA)

Date Filed

October 30, 2019

Case Title

In re: Entresto (Sacubitril/Valsartan) Patent Litigation

Case Number

1:20-md-02930

Court

Delaware

Nature of Suit

Patent - Abbreviated New Drug Application(ANDA)

Date Filed

March 27, 2020

Case Title

Novartis Pharmaceuticals Corporation v. Torrent Pharma Inc.

Case Number

23-2218

Court

Appellate - Federal Circuit

Nature of Suit

835 Patent - (ANDA) (Fed. Qst.)

Date Filed

July 31, 2023

Case Title

NOVARTIS PHARMACEUTICALS CORPORATION v. BECERRA et al

Case Number

3:23-cv-14221

Court

New Jersey

Nature of Suit

Civil Rights: Other

Date Filed

September 01, 2023

Case Title

Novartis Pharmaceuticals Corporation v. Robert F. Kennedy Jr., et al

Case Number

24-5235

Court

Appellate - DC Circuit

Nature of Suit

2890 Other Statutory Actions

Date Filed

October 15, 2024

Case Title

Novartis Pharmaceuticals Corp v. Secretary United States Department of Health, et al

Case Number

24-2968

Court

Appellate - 3rd Circuit

Nature of Suit

2440 Other Civil Rights

Date Filed

October 22, 2024

Recent Articles By Dani